Skip header and navigation

Refine By

   MORE

4 records – page 1 of 1.

Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.

https://arctichealth.org/en/permalink/ahliterature271560
Source
Prim Care Diabetes. 2015 Aug;9(4):253-60
Publication Type
Article
Date
Aug-2015
Author
Ann-Sofie Nilsson Neumark
Lars Brudin
Thomas Neumark
Source
Prim Care Diabetes. 2015 Aug;9(4):253-60
Date
Aug-2015
Language
English
Publication Type
Article
Keywords
Aged, 80 and over
Biomarkers - blood
Blood Glucose - drug effects - metabolism
Cross-Sectional Studies
Diabetes Mellitus, Type 1 - blood - diagnosis - drug therapy - epidemiology
Diabetes Mellitus, Type 2 - blood - diagnosis - drug therapy - epidemiology
Female
Guideline Adherence - standards
Health Services for the Aged - standards
Hemoglobin A, Glycosylated - metabolism
Home Care Services
Homes for the Aged
Humans
Hypoglycemic Agents - adverse effects - therapeutic use
Independent living
Male
Nursing Homes
Practice Guidelines as Topic - standards
Practice Patterns, Physicians' - standards
Prevalence
Process Assessment (Health Care) - standards
Quality Indicators, Health Care - standards
Sweden - epidemiology
Treatment Outcome
Abstract
To compare adherence to Swedish guidelines for diabetes care between elderly people living at home with or without home health care, and residents of nursing homes.
Medical records of 277 elderly people aged 80 and older, with known diabetes in a Swedish municipality, were monitored using quality indicators to evaluate processes and outcomes.
Monitoring, in accordance to diabetes guidelines, of HbA1c, lipids, blood pressure and foot examinations was lower among residents of nursing homes (p
PubMed ID
25865853 View in PubMed
Less detail

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders.

https://arctichealth.org/en/permalink/ahliterature130245
Source
Br J Surg. 2012 Jan;99(1):100-3
Publication Type
Article
Date
Jan-2012
Author
D J Pournaras
E T Aasheim
T T Søvik
R. Andrews
D. Mahon
R. Welbourn
T. Olbers
C W le Roux
Author Affiliation
Imperial Weight Centre, Imperial College London, Charing Cross Hospital, London, UK.
Source
Br J Surg. 2012 Jan;99(1):100-3
Date
Jan-2012
Language
English
Publication Type
Article
Keywords
Adult
Aged
Biological Markers - blood
Blood Glucose - metabolism
Diabetes Mellitus, Type 2 - blood - diagnosis - drug therapy - epidemiology
Female
Gastrectomy - methods
Gastric Bypass - methods
Gastroplasty - methods
Great Britain - epidemiology
Hemoglobin A, Glycosylated - metabolism
Humans
Hypoglycemic Agents - administration & dosage
Insulin - blood
Male
Middle Aged
Norway - epidemiology
Prospective Studies
Retrospective Studies
Time Factors
Treatment Outcome
Abstract
The American Diabetes Association recently defined remission of type II diabetes as a return to normal measures of glucose metabolism (haemoglobin (Hb) A1c below 6 per cent, fasting glucose less than 5·6 mmol/l) at least 1 year after bariatric surgery without hypoglycaemic medication. A previously used common definition was: being off diabetes medication with normal fasting blood glucose level or HbA1c below 6 per cent. This study evaluated the proportion of patients achieving complete remission of type II diabetes following bariatric surgery according to these definitions.
This was a retrospective review of data collected prospectively in three bariatric centres on patients undergoing gastric bypass, sleeve gastrectomy and gastric banding.
Some 1006 patients underwent surgery, of whom 209 had type II diabetes. Median follow-up was 23 (range 12-75) months. HbA1c was reduced after operation in all three surgical groups (P
PubMed ID
22021090 View in PubMed
Less detail

Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.

https://arctichealth.org/en/permalink/ahliterature300941
Source
BMC Cardiovasc Disord. 2018 08 03; 18(1):160
Publication Type
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Date
08-03-2018
Author
John Munkhaugen
Jøran Hjelmesæth
Jan Erik Otterstad
Ragnhild Helseth
Stina Therese Sollid
Erik Gjertsen
Lars Gullestad
Joep Perk
Torbjørn Moum
Einar Husebye
Toril Dammen
Author Affiliation
Department of Medicine, Drammen Hospital, Vestre Viken Health Trust, Dronninggata 41, 3004, Drammen, Norway. johmun@vestreviken.no.
Source
BMC Cardiovasc Disord. 2018 08 03; 18(1):160
Date
08-03-2018
Language
English
Publication Type
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Keywords
Aged
Biomarkers - blood
Blood Glucose - drug effects - metabolism
Cardiac Rehabilitation
Comorbidity
Coronary Artery Disease - diagnosis - epidemiology - therapy
Cross-Sectional Studies
Diabetes Mellitus, Type 2 - blood - diagnosis - drug therapy - epidemiology
Female
Glycated Hemoglobin A - metabolism
Humans
Hypertension - epidemiology
Hypoglycemic agents - therapeutic use
Male
Medication Adherence
Middle Aged
Myocardial Infarction - diagnosis - surgery
Myocardial Revascularization
Norway - epidemiology
Obesity - epidemiology
Prediabetic State - blood - diagnosis - drug therapy - epidemiology
Prevalence
Retrospective Studies
Risk factors
Sleep Initiation and Maintenance Disorders - epidemiology
Smoking - adverse effects - epidemiology
Time Factors
Treatment Outcome
Abstract
Understanding the determinants associated with prediabetes and type 2 diabetes in coronary patients may help to individualize treatment and modelling interventions. We sought to identify sociodemographic, medical and psychosocial factors associated with normal blood glucose (HbA1c
PubMed ID
30075751 View in PubMed
Less detail

Socioeconomic position and cardiovascular risk factors among people with screen-detected Type 2 DM: six-year follow-up of the ADDITION-Denmark trial.

https://arctichealth.org/en/permalink/ahliterature265271
Source
Prim Care Diabetes. 2014 Dec;8(4):322-9
Publication Type
Article
Date
Dec-2014
Author
Else-Marie Dalsgaard
Mogens Vestergaard
Mette Vinther Skriver
Knut Borch-Johnsen
Torsten Lauritzen
Annelli Sandbaek
Source
Prim Care Diabetes. 2014 Dec;8(4):322-9
Date
Dec-2014
Language
English
Geographic Location
Denmark
Publication Type
Article
Keywords
Adult
Aged
Antihypertensive Agents - therapeutic use
Biological Markers - blood
Blood pressure
Body mass index
Cardiovascular Diseases - diagnosis - epidemiology - prevention & control
Chi-Square Distribution
Cholesterol - blood
Comorbidity
Denmark - epidemiology
Diabetes Mellitus, Type 2 - blood - diagnosis - drug therapy - epidemiology
Dyslipidemias - blood - drug therapy - epidemiology
Educational Status
Female
General practice
Health Status Disparities
Hemoglobin A, Glycosylated - metabolism
Humans
Hypertension - drug therapy - epidemiology - physiopathology
Hypoglycemic agents - therapeutic use
Hypolipidemic Agents - therapeutic use
Income
Male
Middle Aged
Multivariate Analysis
Obesity - epidemiology - physiopathology
Registries
Risk factors
Socioeconomic Factors
Time Factors
Abstract
To examine whether socioeconomic position (SEP) was associated with change in cardiovascular risk factors and meeting treatment targets for cardiovascular risk factors among individuals with screen-detected Type 2 DM at six-year follow-up.
The study population was 1533 people with Type 2 DM identified from at stepwise diabetes screening programme in general practice during 2001-2006 in the ADDITION-Denmark study. The ADDITION-study was performed as a randomised trial but the two randomisation groups were analysed as one cohort in this study. Cardiovascular risk factors were measured at baseline and repeated at follow-up (mean: 5.9 [1.4] years). Information on SEP, redeemed antihypertensive and lipid-lowering treatment were obtained from Danish registers. Multivariate analyses were performed to estimate change in cardiovascular risk factors and difference in meeting treatment targets.
The change in HbA1c, cholesterol, blood pressure and BMI were virtually the same across educational level, income level, occupational status or cohabiting status. Overall, the ability to meet treatment targets for HbA1c, cholesterol and blood pressure was not modified by SEP-group. A higher proportion of people with lower educational level or lower income level in the intensive care redeemed anti-hypertensive treatment compared to people with higher educational or income levels.
Screen-detection and early treatment onset did not introduce socioeconomic inequality in metabolic control in people with screen-detected Type 2 DM at six-year follow-up.
PubMed ID
24613817 View in PubMed
Less detail